Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 17A1 (CYP17A1) is a crucial enzyme in human steroid hormone biosynthesis, catalyzing two key reactions: 17α-hydroxylation and 17,20-lyase activity. These activities are essential for the production of glucocorticoids, sex steroids, and mineralocorticoids. The enzyme is localized to the endoplasmic reticulum of cells primarily within adrenal glands, gonads, and placenta. Mutations or deficiencies in CYP17A1 can lead to several disorders, including congenital adrenal hyperplasia and pseudohermaphroditism. Altered CYP17A1 function has implications for diseases such as polycystic ovary syndrome, adrenarche abnormalities, prostate cancer, and other endocrine disorders.
Inhibition of CYP17A1 enzymatic activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 family 17 subfamily A member 1 (CYP17A1).